title: A severe case of warfarin-canrenoate interaction: a role for genetic predisposition?
authors.forename: Valentina
authors.initials: V
authors.lastname: Maggini
authors.forename: Alessandra
authors.initials: A
authors.lastname: Pugi
authors.forename: David
authors.initials: D
authors.lastname: Coletta
authors.forename: Michele
authors.initials: M
authors.lastname: Vietri
authors.forename: Betti
authors.initials: B
authors.lastname: Giusti
authors.forename: Domenico
authors.initials: D
authors.lastname: Prisco
authors.forename: Alessandro
authors.initials: A
authors.lastname: Mugelli
authors.forename: Francesco
authors.initials: F
authors.lastname: Lapi
authors.forename: Alfredo
authors.initials: A
authors.lastname: Vannacci
mesh_terms: D000368:Aged; D000925:Anticoagulants / Q000009:adverse effects*; D002191:Canrenoic Acid / Q000009:adverse effects*; D004347:Drug Interactions; D005260:Female; D020022:Genetic Predisposition to Disease; D006406:Hematoma / Q000209:etiology*; D006801:Humans; D000451:Mineralocorticoid Receptor Antagonists / Q000009:adverse effects*; D014859:Warfarin / Q000009:adverse effects*
chemical_list: D000925:Anticoagulants; D000451:Mineralocorticoid Receptor Antagonists; D014859:Warfarin; D002191:Canrenoic Acid